Supplementary Data Tables S1, S2, S3, and Figs. S1 and S2 from Nano-delivery of RAD6/Translesion Synthesis Inhibitor SMI#9 for Triple-negative Breast Cancer Therapy

Contains Materials, Method of metabolite extraction and 1H-NMR analysis. Supplementary Table S1 shows size measurements of GNPs. Supplementary Table S2 shows summary of metabolic pathway analysis in SUM1315 triple negative breast cancer cells. Supplementary Table S3 shows summary of metabolic pathway analysis in MDA-MB-231 triple negative breast cancer cells. Supplementary Figure S1 shows PCA loading plots of SUM1315 and MDA-MB-231 cells treated with blank-GNP or SMI#9-GNP. Supplementary Figure S2 shows PLS-DA plots of SUM1315 and MDA-MB-231 cells treated with blank-GNP or SMI#9-GNP.